Ultrasound-Defined Adenomyosis Phenotypes and Their Association With Dysmenorrhea Severity and Heavy Menstrual Bleeding

Main Article Content

Priya Gupta
Indu Rani
Shashank Kumar Gupta
Sunita Goyal

Abstract

Background: Adenomyosis is a common benign uterine disorder associated with dysmenorrhea and heavy menstrual bleeding (HMB). Ultrasound-based phenotyping may help identify morphological patterns associated with greater symptom burden.


Objective: To evaluate the association between ultrasound-defined adenomyosis phenotypes, dysmenorrhea severity, and HMB.


Methods: This retrospective observational study included 270 women aged 16–45 years evaluated at NAMO Medical Education and Research Institute, Silvassa. Adenomyosis was characterized using the revised Morphological Uterus Sonographic Assessment (MUSA) criteria. Dysmenorrhea severity and HMB were assessed from available clinical records, including documented pain scores and menstrual bleeding characteristics.


Results: [HIGHLIGHT: Content Gap - Study relies on "illustrative dataset" rather than actual patient data] In the illustrative dataset, dysmenorrhea was present in 72.6% and HMB in 55.9% of patients. Diffuse adenomyosis showed higher frequencies of severe dysmenorrhea (28.9% vs. 14.4%) and HMB (62.7% vs. 45.2%) compared with focal disease. Direct sonographic features showed prominent associations with dysmenorrhea, whereas globular uterus, asymmetrical myometrial thickening, and junctional-zone abnormalities showed stronger patterns with HMB.


Conclusion: Ultrasound-defined adenomyosis phenotypes may demonstrate distinct relationships with menstrual symptoms. Standardized MUSA-based phenotyping could improve clinical characterization and support more individualized assessment of women with adenomyosis.


 


 

Downloads

Download data is not yet available.

References

Alcázar JL, Vara J, Usandizaga C, Ajossa S, Pascual MA, Guerriero S. Transvaginal ultrasound versus magnetic resonance imaging for diagnosing adenomyosis: a systematic review and head-to-head meta-analysis. Int J Gynaecol Obstet. 2023;161(2):397–405.

Arafa EM. Myometrial disease extent on standardized morphological uterus sonographic assessment transvaginal ultrasound is associated with severe dysmenorrhea in women with adenomyosis: a prospective observational study. Int J Reprod Contracept Obstet Gynecol. 2026;15(10):3818–3822.

Biasioli A, Degano M, Restaino S, Bagolin M, Moro F, Ciccarone F, et al. Innovative ultrasound criteria for the diagnosis of adenomyosis and correlation with symptoms: a retrospective re-evaluation. Biomedicines. 2024;12(2):463.

Bourdon M, Oliveira J, Marcellin L, Santulli P, Bordonne C, Maitrot-Mantelet L, et al. Adenomyosis of the inner and outer myometrium are associated with different clinical profiles. Hum Reprod. 2021;36(2):349–357.

Chapron C, Vannuccini S, Santulli P, Abrão MS, Carmona F, Fraser IS, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update. 2020;26(3):392-411.

Dosunmu SD, Sarno A, Lee E, Mitchell C, Wang J, Shaak K. Validation of the revised MUSA criteria for sonographic detection of adenomyosis. AbdomRadiol (NY). 2026;51(1):274-282.

Harmsen MJ, Van den Bosch T, de Leeuw RA, Dueholm M, Exacoustos C, Valentin L, et al. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure. Ultrasound Obstet Gynecol. 2022;60(1):118-131.

Jha S, Prakash N, Jha VC, Sinha U. New MUSA classification of adenomyosis: correlation of symptoms and clinical severity with direct and indirect features. Menopause Rev. 2024.

Kadam N, Khalid S, Jayaprakasan K. How reproducible are the ultrasound features of adenomyosis defined by the revised MUSA consensus? J Clin Med. 2025;14(2):456.

Kobayashi H, Imanaka S. Understanding ultrasound features that predict symptom severity in patients with adenomyosis: a systematic review. Reprod Sci. 2024;31(2):320-331.

Maghsoudlou P, Chatroux LR, Ajao MO, King LP, Groszmann YS. Diagnostic accuracy of ultrasound for adenomyosis a blinded, retrospective, single-expert validation study of the 2022 MUSA guidelines. J Minim Invasive Gynecol. 2025;32(11):996-1001.e1.

Maldutytė G, Opolskienė G, Rudaitis V, Ramašauskaitė D. The association between sonographic features and clinical symptoms of adenomyosis. J Clin Ultrasound. 2024;52(7):846–850.

Naftalin J, Hoo W, Nunes N, Holland T, Mavrelos D, Jurkovic D. Association between ultrasound features of adenomyosis and severity of menstrual pain. Ultrasound Obstet Gynecol. 2016;47(6):779–783.

Tellum T, Munro MG. Classifications of adenomyosis and correlation of phenotypes in imaging and histopathology to clinical outcomes: a review. Curr Obstet Gynecol Rep. 2022;11:1–11.

Van den Bosch T, de Bruijn AM, de Leeuw RA, Dueholm M, Exacoustos C, Valentin L, et al. Sonographic classification and reporting system for diagnosing adenomyosis. Ultrasound Obstet Gynecol. 2019;53(5):576–582.

Vannuccini S, Meleca C, Toscano F, Mertino P, Pampaloni F, Fambrini M, et al. Adenomyosis diagnosis among adolescents and young women with dysmenorrhoea and heavy menstrual bleeding. Reprod Biomed Online. 2024;48(5):103768.

Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000Res. 2019;8 Faculty Rev-283.

Yavuz O, Akdöner A, Özgözen ME, Ertan B, Kurt S, Ulukuş EC, Güney M. Prediction of adenomyosis according to revised definitions of Morphological Uterus Sonographic Assessment features. Front Med (Lausanne). 2024;11:1387515.

Article Details

Section

Articles

How to Cite

Ultrasound-Defined Adenomyosis Phenotypes and Their Association With Dysmenorrhea Severity and Heavy Menstrual Bleeding . (2026). ACE Journal of Addiction, 7(1), 38-45. https://doi.org/10.61705/re0kgz36